NUVESSA
Drug
Allergan Inc.
Total Payments
$21,994
Transactions
190
Doctors
117
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $2,871 | 165 | 103 |
| 2018 | $7.25 | 1 | 1 |
| 2017 | $19,115 | 24 | 13 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $19,055 | 19 | 86.6% |
| Food and Beverage | $2,938 | 171 | 13.4% |
Payments by Type
Research
$19,055
19 transactions
General
$2,938
171 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOBERABILITY OF METRONIDAZOLE VAGINAL GEN 1.3 IN ADOLESCENT FEMALE SUBJECTS WITH BACTERIAL VAGINOSIS | Allergan Inc. | $19,055 | 8 |
Top Doctors Receiving Payments for NUVESSA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Long Beach, CA | $17,098 | 12 |
| , M.D | Obstetrics & Gynecology | Marrero, LA | $320.00 | 1 |
| , MD | Obstetrics & Gynecology | Irving, TX | $320.00 | 2 |
| , MD | Pediatrics | Bardstown, KY | $225.00 | 1 |
| , MD | Family Medicine | Dayton, OH | $225.00 | 1 |
| , MD | Obstetrics & Gynecology | Memphis, TN | $225.00 | 1 |
| , M.D | Pediatrics | Paramount, CA | $225.00 | 1 |
| , MD | Family Medicine | Oxnard, CA | $225.00 | 1 |
| , MD | Addiction Medicine | Columbus, OH | $225.00 | 1 |
| , ARNP | Obstetrics & Gynecology | Lowell, MA | $134.81 | 8 |
| , MD | Obstetrics & Gynecology | Melbourne, FL | $134.81 | 8 |
| , ARNP, WHNP-BC | Obstetrics & Gynecology | Melbourne, FL | $134.81 | 8 |
| , M.D | Obstetrics | Union, NJ | $92.19 | 7 |
| , FNP-C | Family | Bellflower, CA | $56.43 | 5 |
| , M.D | Obstetrics & Gynecology | Paterson, NJ | $52.81 | 3 |
| , M.D | Obstetrics & Gynecology | Paterson, NJ | $52.81 | 3 |
| , M.D | Obstetrics & Gynecology | Cornelius, NC | $50.29 | 3 |
| , MD | Obstetrics & Gynecology | Memphis, TN | $44.71 | 2 |
| , MD | Obstetrics & Gynecology | Memphis, TN | $43.70 | 2 |
| , CM | Advanced Practice Midwife | Brooklyn, NY | $39.73 | 2 |
| Milci Gonzalez | Registered Nurse | Spring Valley, NY | $39.73 | 2 |
| , M.D | Specialist | Houston, TX | $38.34 | 2 |
| , M.D | Specialist | Houston, TX | $38.34 | 2 |
| , M.D | Specialist | Houston, TX | $38.34 | 2 |
| , MD | Obstetrics | Roanoke, VA | $35.59 | 2 |
Ad
Manufacturing Companies
- Allergan Inc. $19,122
- Exeltis, USA Inc. $2,871
Product Information
- Type Drug
- Total Payments $21,994
- Total Doctors 117
- Transactions 190
About NUVESSA
NUVESSA is a drug associated with $21,994 in payments to 117 healthcare providers, recorded across 190 transactions in the CMS Open Payments database. The primary manufacturer is Allergan Inc..
Payment data is available from 2017 to 2024. In 2024, $2,871 was paid across 165 transactions to 103 doctors.
The most common payment nature for NUVESSA is "Unspecified" ($19,055, 86.6% of total).
NUVESSA is associated with 1 research study, including "A MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOBERABILITY OF METRONIDAZOLE VAGINAL GEN 1.3 IN ADOLESCENT FEMALE SUBJECTS WITH BACTERIAL VAGINOSIS" ($19,055).